Desktop Genetics, a UK-based bioinformatics company, said this week that it will use £375,000 ($582,000) in funding to further develop and commercialize AutoClone, its flagship software product for designing, constructing, managing, and exchanging DNA constructs.

The funds come from an equity investment of £275,000 from Boundary Capital, Execute Technologies, and four angel investors. The firm also received an additional £100,000 from a technology strategy board grant.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.